Christopher Bloomstran
Semper Augustus Investments Group
Christopher Bloomstran Merck & Company Inc stake
total: 94
Semper Augustus Investments Group MRK trades
- Total transactions:
- 16
- New positions:
- 1
- Added:
- 5
- Reduced:
- 10
- Held since:
- 2013 Q2 or earlier
- Held for:
- 53+ quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Christopher Bloomstran holds 44,633 Merck & Company Inc (MRK) shares with a market value of roughly $5.74M accounting for 0.65% of the overall portfolio. Semper Augustus Investments Group has held MRK since at least 2013 Q2 with 137,754 shares in our earliest available record. Since at least 2013 Q2, Semper Augustus Investments Group has made 15 more transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $47.08
- Weighted AVG sell price:
- $59.89
Christopher Bloomstran's historical trades in Merck & Company Inc
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.64%
|
44,633
|
$120.29
|
$5,368,904
|
+0.43% (+190)
|
+0%
|
|
2024 Q1
|
1.07%
|
44,443
|
$131.95
|
$5,864,254
|
-0.30% (-132)
|
-0%
|
|
2023 Q4
|
1.02%
|
44,575
|
$109.02
|
$4,859,567
|
+0.29% (+131)
|
+0%
|
|
2023 Q2
|
1.21%
|
44,444
|
$115.39
|
$5,128,393
|
-0.07% (-29)
|
-0%
|
|
2022 Q2
|
1.20%
|
44,473
|
$91.18
|
$4,055,000
|
+0.91% (+400)
|
+0.01%
|
|
2021 Q1
|
1.28%
|
44,073
|
$77.10
|
$3,398,000
|
+0.07% (+29)
|
+0%
|
|
2020 Q1
|
2.14%
|
$76.95
|
+3.60% (+1,532)
|
|||
|
2019 Q3
|
2.05%
|
$84.19
|
-0.49% (-211)
|
|||
|
2017 Q2
|
2.10%
|
$64.09
|
-45.56% (-35,754)
|
|||
|
2016 Q3
|
3.55%
|
$62.41
|
-0.32% (-252)
|
|||
|
2015 Q2
|
3.00%
|
$56.93
|
-0.41% (-325)
|
|||
|
2015 Q1
|
2.95%
|
$57.48
|
-7.81% (-6,700)
|
|||
|
2014 Q4
|
3.11%
|
$56.79
|
-7.55% (-7,000)
|
|||
|
2014 Q3
|
3.37%
|
$59.28
|
-5.11% (-5,000)
|
|||
|
2014 Q1
|
3.20%
|
$56.76
|
-29.04% (-40,000)
|
|||
|
2013 Q2
|
3.78%
|
$46.45
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.